Eastgate Biotech Corp.’s JV partner acquired Raymond Pharmaceutical facility

Eastgate Biotech Corp.’s JV partner acquired Raymond Pharmaceutical facility. The 22,000 square meter facility produces some 40 million finished solid dosage forms each year, including tablets, capsules and syrup. Eastgate will be used to manufacture products for Raymond according to the terms of the original agreement. This collaboration between Eastgate will allow Raymond to produce Oral Mouth Rinse Human Insulin to utilize a high-quality Biological Drugs and efficient outsourced manufacturing system in Pakistan and export globally.